
NEW YORK (AP) - Eye drug maker Alcon Inc. said Wednesday its profit fell 18 percent in the third quarter compared with a year ago, when it received a large tax benefit.
Alcon's profit slipped to $515 million, or $1.71 per share, from $627 million, or $2.07 per share, in the year-ago period, which included a $178 million tax gain.
Revenue rose 6 percent, to $1.61 billion from $1.52 billion, due to greater drug and surgical product revenue.
Thomson Reuters says analysts were expecting a profit of $1.45 per share and $1.54 billion in revenue.
The Swiss company said surgical product revenue grew 7 percent to $739 million, and pharmaceutical revenue rose 8 percent to $659 million. Consumer eye care product revenue fell 3 percent to $216 million.
Alcon raised its adjusted profit forecast for the full year, which excludes one-time costs and benefits, to a range of $6.60 to $6.70 per share. Three months ago, it expected $6.25 to $6.40 per share.
Analysts are expecting $6.72 per share, on average.
Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Click here to find daily tax tips, forms, rules, and FAQ's. Brought to you by Jackson-Hewitt.